Safety and efficacy of uninterrupted vs. minimally interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: two sides of the same coin?
- 24 July 2018
- journal article
- editorial
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 21 (2) , 181-183
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic eventsEP Europace, 2018
- Uninterrupted Direct Oral Anticoagulant and Warfarin Administration in Elderly Patients Undergoing Catheter Ablation for Atrial FibrillationJACC: Clinical Electrophysiology, 2018
- Apixaban in patients at risk of stroke undergoing atrial fibrillation ablationEuropean Heart Journal, 2018
- Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial FibrillationNew England Journal of Medicine, 2017
- Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registriesEuropean Heart Journal, 2016
- Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillationEuropean Heart Journal, 2015
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation ManagementCirculation, 2014
- In-Hospital Complications Associated With Catheter Ablation of Atrial Fibrillation in the United States Between 2000 and 2010Circulation, 2013
- The effect of food on the absorption and pharmacokinetics of rivaroxabanInt. Journal of Clinical Pharmacology and Therapeutics, 2013
- Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial FibrillationCirculation, 2010